SNYDER CAPITAL MANAGEMENT L P
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1050477
San Francisco, CA
Position in TMO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,355,307
+$3,351,996 QoQ
Shares Held
102,432
+4.9% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#282
of 2,619 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SNYDER CAPITAL MANAGEMENT L P holds $115,254,750 across 2 Diagnostics & Research names. TMO ranks #2 (44.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
281,756 | $63,899,443 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
102,432 | $51,355,307 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,355,307 | 102,432 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $48,003,311 | 97,661 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $65,397,885 | 112,862 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $47,670,190 | 98,285 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $23,227,992 | 57,288 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $23,065,252 | 46,353 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,043,990 | 46,218 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,181,039 | 47,175 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,947,640 | 37,880 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||